Ultralife
ULBI
54 hedge funds and large institutions have $34.3M invested in Ultralife in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 7 reducing their positions, and 5 closing their positions.
314% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 7
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
8% more funds holding
Funds holding: 50 → 54 (+4)
1.84% more ownership
Funds ownership: 28.91% → 30.76% (+1.8%)
25% less capital invested
Capital invested by funds: $45.6M → $34.3M (-$11.3M)
73% less call options, than puts
Call options by funds: $7K | Put options by funds: $26K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$452K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$449K |
| 3 |
Millennium Management
New York
|
+$444K |
| 4 |
NA
Navellier & Associates
Reno,
Nevada
|
+$373K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$366K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$1.78M |
| 2 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
-$180K |
| 3 |
JF
Jump Financial
Chicago,
Illinois
|
-$118K |
| 4 |
AG
Algert Global
San Francisco,
California
|
-$106K |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
-$69K |
ULBI Hedge Fund Activity: Q4 2023 in Review
54 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Ultralife (ULBI) for Q4 2023, worth a combined $34.3M — down 25% from $45.6M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ULBI positions and 5 closed out — a net gain of 4 holders — while 29 added to existing stakes and 7 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $452K. The largest seller was EAM Investors, exiting entirely with an estimated $1.78M sold.
- 54 institutional investors held Ultralife (ULBI) as of Q4 2023, up from 50 in Q3 2023.
- Funds reported $34.3M of Ultralife stock for Q4 2023, down 25% quarter-over-quarter.
- 9 funds opened new Ultralife positions in Q4 2023 and 5 closed out, a net change of +4 holders.
- The largest Ultralife buyer in Q4 2023 was Renaissance Technologies, an estimated $452K added.
- The largest Ultralife seller in Q4 2023 was EAM Investors, an estimated $1.78M sold.
Based on aggregated 13F filings for Q4 2023.